Chair: Peter Rossing (DNK) 13:00 – 13:05 Welcome and Introduction Peter Rossing (DNK) 13:05 – 13:25 The Primary Goals of T2D Management – What the
Chairs: Francisco Javier Ampudia-Blasco (ESP), Giesje Nefs (NLD) 13:00 – 13:10 The power of CGM in diabetes management Francisco Javier Ampudia-Blasco (ESP) 13:10 – 14:30
Chair: Melanie Davies (GBR) 13:00 – 13:10 Welcome and introductions Melanie Davies (GBR) 13:10 – 13:30 GLP-1 in the context of gut hormone multiagonism John
Chairs: Javier Escalada San Martin (ESP), Paola Fioretto (ITA) 12:00 – 12:05 Welcome and introduction Javier Escalada San Martin (ESP) 12:05 – 12:25 Finerenone for
Chair: Arya Sharma (DEU) 12:00 – 12:05 Welcome and introductions Arya Sharma (DEU) 12:05 – 12:15 Below the surface – Obesity, related comorbidities, and potential
People, Populations and Practice: Exploring the Journey across Diabetes care – A potential path for lipid lowering treatment in people with ASCVD and Type 2
Chair: F. Javier Ampudia-Blasco (ESP) 10:30 – 10:55 Applying CGM to Improve Glycemic Control with Automated Insulin Delivery Systems in Persons with Type 1 Diabetes
Welcome and Introduction 09:00 – 09:05 Welcome Ben Williams (USA) 09:05 – 09:15 Introduction Alvin C. Powers (USA) Genetic and gene expression studies that aim
Chair: Esteban Jodar (ESP) 09:00 – 09:10 Welcome and introduction Esteban Jodar (ESP) 09:10 – 09:30 Basal insulin treatment in people with T2D: where is
